Advertisement
Organisation › Details
Next Gen Diagnostics (US), Cambridge UK subsidiary
Headquartered in Mountain View, Calif., and with a team based at the world-renowned Wellcome Sanger Institute outside Cambridge, UK, Next Gen Diagnostics has developed the world’s most complete automation of pathogen WGS bioinformatics and has combined that with a highly automated sample preparation and sequencing service to offer hospitals a unique turnkey capability: onsite, 24-hour WGS results to enable transmission detection and outbreak prevention and soon regulated diagnostics. Now deployed, validated and in clinical use, this system has already proven to detect transmission, and in partnership with hospital infection control teams, to prevent outbreaks. *
Start | 2020-05-08 existent | |
Group | Next Gen Diagnostics (US) | |
Today | Next Gen Diagnostics (US) | |
Industry | genomic software tools | |
Industry 2 | genome sequencing | |
Person | Rhodes, Paul A. (Next Gen Diagnostics 202003 CEO + Founder) | |
Region | Hinxton, Cambridgeshire | |
Country | United Kingdom (GB) | |
Street | The BioData Innovation Centre Wellcome Trust Genome Campus | |
City | CB10 1SA Hinxton, Cambridgeshire | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton. | ||
Record changed: 2023-06-26 |
Advertisement
More documents for Next Gen Diagnostics (US)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top